Pan-PPAR Agonists Based on the Resveratrol Scaffold: Biological Evaluation and Docking Studies

被引:15
作者
Li, Wei [1 ]
He, Xinhua [1 ]
Shi, Weiguo [1 ]
Jia, Haoyan [1 ]
Zhong, Bohua [1 ]
机构
[1] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
关键词
metabolic diseases; molecular modeling; pan-PPAR agonists; receptors; resveratrol; CORONARY HEART-DISEASE; STRUCTURAL DETERMINANTS; ALPHA-ISOFORM; IN-VITRO; PROLIFERATOR; DISCOVERY; PTEROSTILBENE; DYSLIPIDEMIA; CHOLESTEROL; METABOLISM;
D O I
10.1002/cmdc.201000360
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
[No abstract available]
引用
收藏
页码:1977 / 1982
页数:6
相关论文
共 32 条
[1]
ARICHI H, 1982, CHEM PHARM BULL, V30, P1766
[2]
FENOFIBRATE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN DYSLIPIDEMIA [J].
BALFOUR, JA ;
MCTAVISH, D ;
HEEL, RC .
DRUGS, 1990, 40 (02) :260-290
[3]
Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[4]
Current, new and future treatments in dyslipidaemia and atherosclerosis [J].
Chong, PH ;
Bachenheimer, BS .
DRUGS, 2000, 60 (01) :55-93
[5]
AN ANTIPLATELET PRINCIPLE OF VERATRUM-FORMOSANUM [J].
CHUNG, MI ;
TENG, CM ;
CHENG, KL ;
KO, FN ;
LIN, CN .
PLANTA MEDICA, 1992, 58 (03) :274-276
[6]
CREASY LL, 1988, J AM SOC HORTIC SCI, V113, P230
[7]
INHIBITION OF HUMAN LDL OXIDATION BY RESVERATROL [J].
FRANKEL, EN ;
WATERHOUSE, AL ;
KINSELLA, JE .
LANCET, 1993, 341 (8852) :1103-1104
[8]
Role of peroxisome proliferator-activated receptor-α (PPARα) in bezafibrate-induced hepatocarcinogenesis and cholestasis [J].
Hays, T ;
Rusyn, I ;
Burns, AM ;
Kennett, MJ ;
Ward, JM ;
Gonzalez, FJ ;
Peters, JM .
CARCINOGENESIS, 2005, 26 (01) :219-227
[9]
DIET, ALCOHOL AND CORONARY HEART-DISEASE IN MEN [J].
HEGSTED, DM ;
AUSMAN, LM .
JOURNAL OF NUTRITION, 1988, 118 (10) :1184-1189
[10]
INAMORI Y, 1987, CHEM PHARM BULL, V35, P887